Breast cancer subtype has to be accounted for to predict response to neoadjuvant chemotherapy based on radiomic features in 18F-FDG PET

Conclusions: We demonstrated the existence of significant differences in breast tumor metabolic phenotype on 18F-FDG PET/CT and in BC prognostic factors as a function of BC subtype and defined specific "radiomic" and "IHC" dictionaries for each subtype. Combining RF and BC factors from the Luminal B HER2+ dictionaries could help predict pCR.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Boughdad, S., Orlhac, F., Nioche, C., DIRAND, A.-S., Champion, L., Buvat, I. Tags: Breast Cancer Posters Source Type: research